Arena Pharmaceuticals Inc buy KongVestor
Summary
This prediction ended on 11.06.22 with a price of €91.00. KongVestor's BUY prediction for Arena Pharmaceuticals Inc closed unchanged from the start price. KongVestor has 50% into this predictionArena Pharmaceuticals, Inc. (Symbol ARNA) is a biopharmaceutical company based in San Diego, California that focuses on the research, development, and commercialization of novel medications. The company's primary focus is on developing small molecule drugs that target G protein-coupled receptors, which are involved in a wide range of physiological processes. Arena has a diverse pipeline of potential drug candidates in various stages of development, including treatments for pulmonary arterial hypertension, pain, autoimmune diseases, and more. The company's stock is listed on the NASDAQ exchange and is widely considered to be a high-risk/high-reward investment.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arena Pharmaceuticals Inc | - | - | - |
iShares Core DAX® | 0.559% | 3.148% | 14.852% |
iShares Nasdaq 100 | -0.854% | 1.869% | 35.463% |
iShares Nikkei 225® | 1.291% | 4.293% | 14.965% |
iShares S&P 500 | 0.492% | 1.945% | 30.310% |
Comments by KongVestor for this prediction
In the thread Arena Pharmaceuticals Inc diskutieren